Tim West, Ph.D.
Affiliations: | Washington University, Saint Louis, St. Louis, MO |
Area:
Alzheimer's, amyloidGoogle:
"Tim West"Mean distance: 16.52 (cluster 31)
Parents
Sign in to add mentor| David M. Holtzman | grad student | 2006 | Washington University | |
| (Neuronal cell death following hypoxia-ischemia in the neonatal brain.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cook JD, Malik A, Plante DT, et al. (2023) Associations of Sleep Duration and Daytime Sleepiness with Plasma Amyloid Beta and Cognitive Performance in Cognitively Unimpaired, Middle-Aged and Older Adult African Americans. Sleep |
| Rissman RA, Langford O, Raman R, et al. (2023) Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Fischer B, Van Hulle CA, Langhough R, et al. (2023) Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohort. Alzheimer's & Dementia (New York, N. Y.). 9: e12414 |
| Monane M, Johnson KG, Snider BJ, et al. (2023) A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment. Annals of Clinical and Translational Neurology |
| Fogelman I, West T, Braunstein JB, et al. (2023) Independent study demonstrates amyloid probability score accurately indicates amyloid pathology. Annals of Clinical and Translational Neurology |
| Wisch JK, Gordon BA, Boerwinkle AH, et al. (2023) Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12405 |
| Winston CN, Langford O, Levin N, et al. (2023) Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Aschenbrenner AJ, Li Y, Henson RL, et al. (2022) Comparison of plasma and CSF biomarkers in predicting cognitive decline. Annals of Clinical and Translational Neurology |
| Schindler SE, Karikari TK, Ashton NJ, et al. (2022) Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology |
| Hu Y, Kirmess KM, Meyer MR, et al. (2022) Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment. Jama Network Open. 5: e228392 |